Condition
Stage IV Mantle Cell Lymphoma
ClinicalTrials.gov condition label
Advertisement
Clinical trials
8 shownGene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell TransplantNCT02797470 · 2016-06-23
ACTIVE_NOT_RECRUITINGMechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell TransplantNCT01558778 · 2012-05-01
WITHDRAWNDeferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic MalignanciesNCT01273766 · 2011-01-01
COMPLETEDDeferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron OverloadNCT01159067 · 2010-07-01
TERMINATEDRO4929097 and Capecitabine in Treating Patients With Refractory Solid TumorsNCT01158274 · 2010-06-01
COMPLETEDOndansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell TransplantNCT00795769 · 2008-08-08
COMPLETEDLithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell TransplantNCT00408681 · 2006-06-01
COMPLETEDFludarabine and Total-Body Irradiation Followed By Donor Stem Cell Transplant and Cyclosporine and Mycophenolate Mofetil in Treating HIV-Positive Patients With or Without CancerNCT00112593 · 1999-11-01
COMPLETEDCommon interventions
laboratory biomarker analysisOTHER5deferasiroxDRUG2management of therapy complicationsPROCEDURE2Peripheral Blood Stem Cell TransplantationPROCEDURE2Autologous Hematopoietic Stem Cell TransplantationPROCEDURE1capecitabineDRUG1CarmustineDRUG1cyclosporineDRUG1CytarabineDRUG1enzyme-linked immunosorbent assayOTHER1EtoposideDRUG1fludarabine phosphateDRUG1gamma-secretase/Notch signalling pathway inhibitor RO4929097DRUG1Lentivirus Vector CCR5 shRNA/TRIM5alpha/TAR Decoy-transduced Autologous CD34-positive Hematopoietic Progenitor CellsBIOLOGICAL1lithium carbonateDRUG1MelphalanDRUG1musculoskeletal complications management/preventionPROCEDURE1mycophenolate mofetilDRUG1ondansetronDRUG1survey administrationOTHER1total-body irradiationRADIATION1
Leading sponsors
Trial status mix
COMPLETED5
ACTIVE_NOT_RECRUITING1
TERMINATED1
WITHDRAWN1
Phase mix
PHASE24
NA3
PHASE12
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.